Latest Clinical trial Stories
NEW YORK, Feb. 9, 2015 /PRNewswire/ -- Immune Pharmaceuticals Inc. ("Immune", the "Company") (NASDAQ: IMNP) announced the appointment Dr.
ROCKVILLE, Md., Feb. 9, 2015 /PRNewswire/ -- CASI Pharmaceuticals, Inc.
Tuesday, in Angewandte Chemie, scientists at the Institute for Research in Biomedicine (IRB Barcelona) presented a shuttle able to cross the blood-brain barrier and transport various substances into the brain.
The two companies are in the early planning stages of pursuing shared business development opportunities that can deliver synergistic advantages to their respective customers. Frederick,
Researchers at Nationwide Children's Hospital have developed a way to measure upper extremity movement in patients with muscular dystrophy using interactive video game technology. Their hope is to expand inclusion criteria for clinical trials to incorporate patients using wheelchairs.
SHANGHAI, Feb. 6, 2015 /PRNewswire/ -- WuXiPRA, a leading clinical services company with operations in the greater China region, today announced appointments of two key executives.
BETHESDA, Md., Feb. 6, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a U.S.
The Alliance for Clinical Research Excellence and Safety (ACRES) welcomes Dr.
Nation’s premier Internet resource for clinicians, advocates and patients unveils Rare Disease Report™, a new print publication, during World Symposium in Orlando, expanding RDC’s influence
Funding will fuel TrialReach's clinical trial platform growth and expansion into the U.S. LONDON, Feb.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.